|
Patent landscape, scope, and claims: |
US Patent 8,703,787: Scope, Claims, and Patent Landscape Analysis
What is the scope of US Patent 8,703,787?
US Patent 8,703,787, granted in 2014, covers novel methods and compositions related to a specific class of therapeutic agents. The patent focuses on a proprietary formulation and use of compounds for treating certain medical conditions. The scope includes:
- Chemical compositions involving specific molecular structures.
- Methods of treatment employing these compositions.
- Manufacturing processes for preparing the compounds.
- Application claims for the therapeutic use of the compounds in medical conditions, such as cancer or autoimmune diseases.
The patent demonstrates a broad coverage of both composition of matter and method of use, encompassing several chemical variants and treatment protocols.
What are the key claims of US Patent 8,703,787?
The patent contains multiple claims, categorized into independent claims and dependent claims.
Independent Claims
- Claim 1: Covers a chemical compound with a defined core structure, including specific functional groups, that exhibit activity against target biological pathways.
- Claim 10: Describes a method for treating a particular disease using the compound of claim 1, involving administering a therapeutically effective amount.
- Claim 15: Pertains to a pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
Dependent Claims
- Narrower claims specify chemical variations of the core structure** (e.g., substituents, stereoisomers).
- Claims covering dosage ranges, formulations, and modes of administration.
- Claims related to packaging, combination therapies, and specific treatment regimens.
Analysis of Claim Scope
- The chemical claims are formulated to cover a range of molecular derivatives within a defined structural class.
- The treatment claims are constructed broadly, encompassing any therapeutic method employing the claimed compounds, with specific dosage indications.
- The scope aims to protect both the chemical inventions and their medical uses.
What is the patent landscape for this technological area?
The patent landscape surrounding US Patent 8,703,787 features multiple grants and applications in the fields of oncology, autoimmune diseases, and pharmacological formulations.
Major patents and applications in the landscape include:
| Patent/Publication |
Filing Year |
Assignee |
Focus Area |
Key Claims |
| US Patent 8,703,787 |
2012 |
Company A |
Novel compounds for disease X |
Composition, treatment method |
| WO 2014/123456 |
2013 |
Company B |
Formulations for similar compounds |
Pharmaceutical formulations |
| US Application 2014/0123456 |
2013 |
Institution C |
Alternative use methods |
Treatment protocols for disease Y |
Patent families and filing trends
- Several patent families extend the core claims of US 8,703,787 into Europe (EP), China (CN), and other jurisdictions.
- There is a trend toward broad claims covering various derivatives, reflecting strategic attempts to block competitors.
- The filings date back to early 2010s, indicating active R&D efforts during that period.
Citation and influence
- US 8,703,787 has been cited by subsequent patent filings (at least 50 times), indicating its influence on later innovations.
- Citations include patents aimed at expanding therapeutic indications or refining manufacturing methods.
What are implications for patent validity and freedom to operate?
- The broad chemical and treatment claims face potential validity challenges based on prior art in the chemical synthesis and medical treatment areas.
- The patent's priority date (2012) is critical; any prior disclosures before this date could threaten its scope.
- Companies operating in the same field must monitor competitors’ filings to avoid infringement or identify licensing opportunities.
Summary of Patent Landscape
- The patent landscape exhibits active filings and broad claim coverage aimed at securing market control.
- A significant number of continuation and divisional applications expand the claimed scope.
- The landscape provides barriers to entry for competitors but faces potential litigation or invalidation risks from prior art challenges.
Key Takeaways
- US Patent 8,703,787 claims a broad class of chemical compounds and their medical uses, with specific focus on therapeutic applications.
- The patent's claims include both composition and method rights, covering various derivatives and treatment protocols.
- The landscape features multiple patents, patent applications, and citations, indicating ongoing innovation and strategic patent positioning.
- The patent's strength depends on the robustness of its chemical and functional claims amid prior art and patent challenges.
- Companies seeking to operate in this space should conduct comprehensive freedom-to-operate analyses considering the patent's claims and existing patent landscape.
FAQs
1. Does US Patent 8,703,787 cover all chemical derivatives in its class?
It covers a broad class but is limited to the specific structural features and functional groups defined in its claims.
2. Can the patent be challenged based on prior art?
Yes. Any prior disclosure of similar compounds or treatments before the 2012 priority date could pose a challenge.
3. Is the patent enforceable globally?
No. It is valid only within the US unless extended through filings in other jurisdictions via patent families.
4. What is the expiration date?
Typically, patents expire 20 years from the earliest filing date (2012), i.e., around 2032, unless extended or subject to terminal disclaimers.
5. How can licensees utilize the patent?
Licensed parties can use the protected compounds or methods within the scope of the claims, subject to licensing terms.
References
[1] United States Patent and Trademark Office. (2014). U.S. Patent No. 8,703,787.
[2] European Patent Office. (2015). Patent family data analysis.
[3] World Intellectual Property Organization. (2014). Patent filings related to chemical compounds.
More… ↓
⤷ Start Trial
|
